{
    "_index": "corpus_doc_business100_en",
    "_id": "44570489",
    "_source": {
        "identificationMetadata": {
            "id": "44570489",
            "title": "OncoMed",
            "url": [
                "https://en.wikipedia.org/?curid=44570489",
                "https://en.wikipedia.org/wiki/OncoMed"
            ],
            "version": 1112516297,
            "versionDate": "2022-09-26T18:31:48Z",
            "hash": "ffa05b2f9d5fa0575b23dd37e7e42642",
            "wikidata": "Q18635282"
        },
        "descriptionMetadata": {
            "categories": [
                "CS1 maint: archived copy as title",
                "Pages with login required references or sources",
                "Articles containing potentially dated statements from 2013",
                "All articles containing potentially dated statements",
                "Articles containing potentially dated statements from January 2017",
                "Articles containing potentially dated statements from 2007",
                "Articles with ISNI identifiers",
                "2004 establishments in California",
                "2019 mergers and acquisitions",
                "American companies established in 2004",
                "Companies based in Redwood City, California",
                "Companies formerly listed on the Nasdaq",
                "Pharmaceutical companies established in 2004"
            ],
            "language": "en",
            "source": "wikipedia"
        },
        "contentMetadata": {
            "format": "wikitext",
            "content": "{{infobox company\n| name             = OncoMed Pharmaceuticals, Inc.\n| type             = Private (2004-13)<br />[[Public company|Public]] (2013-19)\n| industry         = [[Pharmaceutical]]\n| foundation       = [[University of Michigan]]\n| fate = Acquired by Mereo BioPharma\n| defunct = {{End date|2019|04|23}}\n| founders         = {{ubl|Michael Clarke|Max Wicha}}\n| key_people       = {{ubl|Paul Hastings (CEO)|John Lewicki (R&D chief)|Chuck Alaimo (Operations director)}}\n| location_city    = [[Redwood City, California]]\n| location_country = United States\n| num_employees    = {{ubl|83 (2013)|47 (2007)}}\n| assets           = {{currency|207.6 million|US}} <ref>{{Cite web |url=http://investor.shareholder.com/oncomed/secfiling.cfm?filingID=1564590-16-26741&CIK=1302573 |title=Archived copy |access-date=2017-01-05 |archive-date=2017-01-06 |archive-url=https://web.archive.org/web/20170106011610/http://investor.shareholder.com/oncomed/secfiling.cfm?filingID=1564590-16-26741&CIK=1302573 |url-status=dead }}</ref>\n| assets_year      = 2016\n| traded_as        = {{NASDAQ was|OMED}}\n| revenue          = {{currency|24.7 million|US}} (2012)\n| footnotes        = <ref name=\"leuty2007\"/><ref name=\"timmerman2013\"/><ref name=\"uofmhs2013pr\"/><ref name=\"leuty2014\"/>\n}}\n'''OncoMed Pharmaceuticals, Inc.''' was a public American pharmaceutical development company headquartered in [[Redwood City, California]].<ref name=\"leuty2007\" />  The company was founded in August 2004 by two [[University of Michigan]] investigators, Michael Clarke and Max S. Wicha.<ref name=\"leuty2007\" /><ref name=\"uofmhs2013pr\" />  {{As of|2013}}, the company had 83 employees.<ref name=\"timmerman2013\" />  OncoMed's drug discovery work focuses on developing \"targeted antibodies against [[cancer stem cell]]s\".<ref name=\"timmerman2013\" />  The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company.<ref name=\"uofmhs2013pr\" />  OncoMed [[Initial public offering|went public]] in 2013 and was listed on [[NASDAQ]] under the [[stock symbol]] OMED.<ref name=\"timmerman2013\" /><ref name=\"uofmhs2013pr\" /> In April 2019 the company was acquired by [[Mereo BioPharma]] and delisted from the Nasdaq.\n\n==History==\nOncomed was founded in 2004.<ref>{{Cite web|url=https://www.bizjournals.com/sanfrancisco/blog/biotech/2012/05/oncomed-ipo-cancer.html|title=OncoMed files for $115 million IPO|last=Leuty|first=Ron|date=11 May 2012|website=San Francisco Business Times|access-date=2020-04-21}}</ref>\n\nIn 2007, Oncomed consolidated its operations located in [[Mountain View, California|Mountain View]] and [[Palo Alto, California]] onto the single headquarters campus at [[Seaport Centre]] in Redwood City.<ref name=\"leuty2007\" />  One of the buildings on the new campus was the former home of [[NeXT]].<ref name=\"leuty2007\" />\n\nIn 2012, OncoMed sponsored the [[United States Adopted Name|USAN]] nonproprietary name [[vantictumab]] for a human [[IgG2]] anti-[[Frizzled]] antibody, an anti-cancer therapeutic.<ref name=\"vantictumab_usan\" />  In the same year, the company sponsored the USAN name [[demcizumab]] for a human IgG2 anti-[[DLL4]] antibody, also an anti-cancer therapeutic.<ref name=\"demcizumab_usan\" />\n\nIn 2014, OncoMed entered into an anti-[[cancer stem cell]] therapeutic development agreement with [[Celgene]] encompassing [[demcizumab]] and five other biologics from OncoMed's pipeline.<ref name=\"de2014\" /><ref name=\"genengbionews2014collab\" />\n\n{{As of|2013}}, co-founder Max Wicha was the director of the University of Michigan Comprehensive Cancer Center and remained a consultant to OncoMed, while co-founder Michael Clarke had taken up a position at [[Stanford University]].<ref name=\"uofmhs2013pr\" />\n\n===Competitors===\nIn 2013, OncoMed had at least two direct competitors, both public American companies: Stemline Therapeutics and Verastem.<ref name=\"timmerman2013\" />  By 2014, the list of firms pursuing therapies targeting [[cancer stem cell]]s had grown to include Boston Biomedical (a subsidiary of [[Dainippon Sumitomo Pharma]]), [[GlaxoSmithKline]], [[Astellas Pharma]], [[Sanofi]] (the American subsidiary) and [[Pfizer]]; however, Stemline and Verastem remain the only two competitors solely focused on cancer stem cells.<ref name=\"de2014\" />  One analyst holds that OncoMed is the best positioned of the three companies focused on the cancer stem cell area.<ref name=\"de2014\" />\n\n==Pipeline==\n{| class=\"wikitable floatleft\"\n|+ Clinical pipeline, Oct 2014<ref name=\"de2014\" />\n|-\n! Name !! Target || ID !! Clinical Phase\n|-\n| [[demcizumab]] || DLL4 || OMP-21M18 || II\n|-\n| [[tarextumab]] || Notch 2/3 || OMP-59R5<ref name=\"omppr2013\" /> || II\n|-\n| [[vantictumab]] || Fzd7 || OMP-18R5<ref name=\"leuty2014\" /> || Ib\n|-\n| [[ipafricept]] || Fzd8-fc || OMP-54F28<ref name=\"grover2014\" /> || Ib\n|-\n| [[brontictuzumab]] || Notch1 || OMP-52M51 || I\n|-\n| unnamed || DLL4/VEGF || OMP-305B83 || I\n|- \n| unnamed || RSPO3 || OMP-131R10 || I\n|}\n{{As of|January 2017}}, Oncomed had seven clinical-stage drugs in development and four discovery-stage investigations; no OncoMed therapies have made it to market yet.<ref name=\"de2014\" />  Two candidate drugs being co-developed with [[Bayer]], ipafricept and vantictumab, showed in mid-2014 indications of \"causing mild-to-moderate bone-related side effects\" among Phase I clinical trial participants, an observation which led the company to halt enrollment and dosing in the trials, and which contributed to a sharp decline in share price.<ref name=\"de2014\" /><ref name=\"grover2014\" /><ref name=\"calia2014\" />\n\nDemcizumab, OMP-305B83, and OMP-131R10 are being developed in collaboration with [[Celgene]]. Tarextumab and brontictuzumab are being developed in collaboration with [[GlaxoSmithKline]] Vantictumab and ipafricept are being developed in collaboration with [[Bayer]].<ref>{{Cite web|url=http://www.oncomed.com/Pipeline.html|title=Home &#124; Mereo BioPharma}}</ref>\n\n==Corporate governance==\nIn 2013, OncoMed's [[chief executive officer]] (CEO) was Paul Hastings,<ref name=\"timmerman2013\" /> who took the post in 2006.<ref name=\"chidirectorbio\" />  {{As of|2007}}, the company's head of R&D was John Lewicki, and the director of operations was Chuck Alaimo.<ref name=\"leuty2007\" /> While serving as OncoMed's CEO, Hastings was also a member of the [[board of directors]] for the [[California Healthcare Institute]] and the Bay Area Biosciences Association, as well as chairing the board of the [[Biotechnology Industry Organization]].<ref name=\"chidirectorbio\" />\n\n==References==\n{{reflist|33em|refs=\n\n* <ref name=\"calia2014\">{{cite news | author=Calia, Michael | title=FDA Imposes Partial Hold on OncoMed Early-Stage Cancer-Drug Trial | date=13 Jun 2014 | work=[[The Wall Street Journal]] | url=https://online.wsj.com/articles/oncomed-halts-early-stage-trials-for-two-cancer-drugs-1402665121 <!--not properly preserved in archive.org--> }}</ref>\n* <ref name=\"chidirectorbio\">{{cite web | title=Paul J. Hastings | publisher=[[California Healthcare Institute]] | website=Leadership | url=http://www.chi.org/about/leadership/hastings.aspx | url-status=dead<!--returns a 403 Forbidden error--> | archive-date=2 October 2011 | archive-url=https://web.archive.org/web/20111002104016/http://www.chi.org/about/leadership/hastings.aspx }}</ref>\n* <ref name=\"de2014\">{{cite news | author=De, Kanak Kanti | title=Is It Time To Consider OncoMed Pharmaceuticals Again? | date=14 Oct 2014 | work=[[Seeking Alpha]] | url=http://seekingalpha.com/article/2560445-is-it-time-to-consider-oncomed-pharmaceuticals-again <!--addition to archive.org failed--> }}</ref>\n* <ref name=\"demcizumab_usan\">{{cite web | title=Statement on a nonproprietary name adopted by the USAN Council | url=https://download.ama-assn.org/resources/doc/usan/x-pub/demcizumab.pdf?cb=1417490455&retrieve=yes | format=PDF | access-date=1 Dec 2014 | id=N12/07 | publisher=[[American Medical Association|AMA]] }}{{registration required}}</ref>\n* <ref name=\"genengbionews2014collab\">{{cite news | title=OncoMed, Celgene in $3.3B+ Cancer Stem Cell Collaboration | author=Staff | date=January 1, 2014 | page=8 | work=[[Gen. Eng. Biotechnol. News]] | department=Industry Watch }}</ref>\n* <ref name=\"grover2014\">{{cite news | work=[[Reuters]] | author=Grover, Natalie | title=OncoMed halts enrollment in trials of two cancer drugs | date=13 Jun 2014 | url=https://www.reuters.com/article/us-oncomed-study-idUSKBN0EO1B920140613 <!--present in archive.org--> }}</ref>\n* <ref name=\"leuty2007\">{{cite news | author=Leuty, Ron | title=The NeXT big thing: OncoMed finds a home | date=28 Oct 2007 | work=[[San Francisco Business Times]] | url=http://www.bizjournals.com/sanfrancisco/stories/2007/10/29/focus6.html?page=all }}</ref>\n* <ref name=\"leuty2014\">{{cite news | author=Leuty, Ron | title=OncoMed targets 4 million shares in IPO | date=5 Jul 2013 | work=[[San Francisco Business Times]] | url=http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/07/oncomed-ipo-cancer-stem-cells-bayer-gsk.html <!--added to archive.org--> }}</ref>\n* <ref name=\"omppr2013\">{{cite press release | publisher=OncoMed | title=OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 (Anti-Notch2/3) in Small Cell Lung Cancer (SCLC) and Amends Phase1b/2 Pancreatic Cancer Trial | url=http://files.shareholder.com/downloads/AMDA-20K1SK/3646503054x0x675682/d0fd1bf7-5edd-4aa2-8dca-e525ac9867a2/675682.pdf <!--present in archive.org--> | date=14 May 2013 }}</ref>\n* <ref name=\"timmerman2013\">{{cite news | author=Timmerman, Luke | work=[[Xconomy]] | location=United States | date=18 Jun 2013 | title=OncoMed Pharmaceuticals Soars in IPO Debut | url=http://www.xconomy.com/san-francisco/2013/07/18/oncomed-pharmaceuticals-soars-in-ipo-debut/ <!--present in archive.org--> }}</ref>\n* <ref name=\"uofmhs2013pr\">{{cite press release | publisher=[[University of Michigan Health System]] | title=U-M start-up OncoMed has initial public offering | date=22 Jul 2013 | url=http://www.uofmhealth.org/news/archive/201307/u-m-start-oncomed-has-initial-public-offering  <!--present in archive.org--> }}</ref>\n* <ref name=\"vantictumab_usan\">{{cite web | title=Statement on a nonproprietary name adopted by the USAN Council | url=https://download.ama-assn.org/resources/doc/usan/x-pub/vantictumab.pdf?cb=1417489538&retrieve=yes | format=PDF | date=28 Nov 2012 | id=N12/155 | publisher=[[American Medical Association|AMA]] }}{{registration required}}</ref>\n\n}}\n\n==External links==\n* {{Official website}}\n* {{Finance links\n| name = OncoMed\n| symbol = OMED\n| sec_cik = 1302573\n| yahoo = OMED\n| google = OMED\n| bloomberg = OMED:US\n}}\n\n{{Authority control}}\n\n[[Category:2004 establishments in California]]\n[[Category:2019 mergers and acquisitions]]\n[[Category:American companies established in 2004]]\n[[Category:Companies based in Redwood City, California]]\n[[Category:Companies formerly listed on the Nasdaq]]\n[[Category:Pharmaceutical companies established in 2004]]",
            "text": "OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. As of 2013[update], the company had 83 employees. OncoMed's drug discovery work focuses on developing \"targeted antibodies against cancer stem cells\". The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company. OncoMed went public in 2013 and was listed on NASDAQ under the stock symbol OMED. In April 2019 the company was acquired by Mereo BioPharma and delisted from the Nasdaq. Oncomed was founded in 2004. In 2007, Oncomed consolidated its operations located in Mountain View and Palo Alto, California onto the single headquarters campus at Seaport Centre in Redwood City. One of the buildings on the new campus was the former home of NeXT. In 2012, OncoMed sponsored the USAN nonproprietary name vantictumab for a human IgG2 anti-Frizzled antibody, an anti-cancer therapeutic. In the same year, the company sponsored the USAN name demcizumab for a human IgG2 anti-DLL4 antibody, also an anti-cancer therapeutic. In 2014, OncoMed entered into an anti-cancer stem cell therapeutic development agreement with Celgene encompassing demcizumab and five other biologics from OncoMed's pipeline. As of 2013[update], co-founder Max Wicha was the director of the University of Michigan Comprehensive Cancer Center and remained a consultant to OncoMed, while co-founder Michael Clarke had taken up a position at Stanford University. In 2013, OncoMed had at least two direct competitors, both public American companies: Stemline Therapeutics and Verastem. By 2014, the list of firms pursuing therapies targeting cancer stem cells had grown to include Boston Biomedical (a subsidiary of Dainippon Sumitomo Pharma), GlaxoSmithKline, Astellas Pharma, Sanofi (the American subsidiary) and Pfizer; however, Stemline and Verastem remain the only two competitors solely focused on cancer stem cells. One analyst holds that OncoMed is the best positioned of the three companies focused on the cancer stem cell area. As of January 2017[update], Oncomed had seven clinical-stage drugs in development and four discovery-stage investigations; no OncoMed therapies have made it to market yet. Two candidate drugs being co-developed with Bayer, ipafricept and vantictumab, showed in mid-2014 indications of \"causing mild-to-moderate bone-related side effects\" among Phase I clinical trial participants, an observation which led the company to halt enrollment and dosing in the trials, and which contributed to a sharp decline in share price. Demcizumab, OMP-305B83, and OMP-131R10 are being developed in collaboration with Celgene. Tarextumab and brontictuzumab are being developed in collaboration with GlaxoSmithKline Vantictumab and ipafricept are being developed in collaboration with Bayer. In 2013, OncoMed's chief executive officer (CEO) was Paul Hastings, who took the post in 2006. As of 2007[update], the company's head of R&D was John Lewicki, and the director of operations was Chuck Alaimo. While serving as OncoMed's CEO, Hastings was also a member of the board of directors for the California Healthcare Institute and the Bay Area Biosciences Association, as well as chairing the board of the Biotechnology Industry Organization. \"Archived copy\". Archived from the original on 2017-01-06. Retrieved 2017-01-05.{{cite web}}: CS1 maint: archived copy as title (link) Leuty, Ron (28 Oct 2007). \"The NeXT big thing: OncoMed finds a home\". San Francisco Business Times. Timmerman, Luke (18 Jun 2013). \"OncoMed Pharmaceuticals Soars in IPO Debut\". Xconomy. United States. \"U-M start-up OncoMed has initial public offering\" (Press release). University of Michigan Health System. 22 Jul 2013. Leuty, Ron (5 Jul 2013). \"OncoMed targets 4 million shares in IPO\". San Francisco Business Times. Leuty, Ron (11 May 2012). \"OncoMed files for $115 million IPO\". San Francisco Business Times. Retrieved 2020-04-21. \"Statement on a nonproprietary name adopted by the USAN Council\" (PDF). AMA. 28 Nov 2012. N12/155.(registration required) \"Statement on a nonproprietary name adopted by the USAN Council\" (PDF). AMA. N12/07. Retrieved 1 Dec 2014.(registration required) De, Kanak Kanti (14 Oct 2014). \"Is It Time To Consider OncoMed Pharmaceuticals Again?\". Seeking Alpha. Staff (January 1, 2014). \"OncoMed, Celgene in $3.3B+ Cancer Stem Cell Collaboration\". Industry Watch. Gen. Eng. Biotechnol. News. p.Â 8. \"OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 (Anti-Notch2/3) in Small Cell Lung Cancer (SCLC) and Amends Phase1b/2 Pancreatic Cancer Trial\" (PDF) (Press release). OncoMed. 14 May 2013. Grover, Natalie (13 Jun 2014). \"OncoMed halts enrollment in trials of two cancer drugs\". Reuters. Calia, Michael (13 Jun 2014). \"FDA Imposes Partial Hold on OncoMed Early-Stage Cancer-Drug Trial\". The Wall Street Journal. \"Home | Mereo BioPharma\". \"Paul J. Hastings\". Leadership. California Healthcare Institute. Archived from the original on 2 October 2011. Official website Business data for OncoMed: Bloomberg Google SEC filings Yahoo!"
        },
        "collectMetadata": {
            "requestedDate": "2023-10-16T00:00:00",
            "ingestedDate": "2023-10-21T09:37:22.277395"
        },
        "extractionMetadata": [
            {
                "id": "WikitextExtractor",
                "linkExtractionDate": "2023-10-21T09:37:22.281796",
                "links": [
                    {
                        "fragment": null,
                        "link": "Public_company",
                        "text": "Public",
                        "title": "Public company"
                    },
                    {
                        "fragment": null,
                        "link": "Pharmaceutical",
                        "text": null,
                        "title": "Pharmaceutical"
                    },
                    {
                        "fragment": null,
                        "link": "University_of_Michigan",
                        "text": null,
                        "title": "University of Michigan"
                    },
                    {
                        "fragment": null,
                        "link": "Redwood_City,_California",
                        "text": null,
                        "title": "Redwood City, California"
                    },
                    {
                        "fragment": null,
                        "link": "Redwood_City,_California",
                        "text": null,
                        "title": "Redwood City, California"
                    },
                    {
                        "fragment": null,
                        "link": "University_of_Michigan",
                        "text": null,
                        "title": "University of Michigan"
                    },
                    {
                        "fragment": null,
                        "link": "Cancer_stem_cell",
                        "text": null,
                        "title": "cancer stem cell"
                    },
                    {
                        "fragment": null,
                        "link": "Initial_public_offering",
                        "text": "went public",
                        "title": "Initial public offering"
                    },
                    {
                        "fragment": null,
                        "link": "NASDAQ",
                        "text": null,
                        "title": "NASDAQ"
                    },
                    {
                        "fragment": null,
                        "link": "Stock_symbol",
                        "text": null,
                        "title": "stock symbol"
                    },
                    {
                        "fragment": null,
                        "link": "Mereo_BioPharma",
                        "text": null,
                        "title": "Mereo BioPharma"
                    },
                    {
                        "fragment": null,
                        "link": "Mountain_View,_California",
                        "text": "Mountain View",
                        "title": "Mountain View, California"
                    },
                    {
                        "fragment": null,
                        "link": "Palo_Alto,_California",
                        "text": null,
                        "title": "Palo Alto, California"
                    },
                    {
                        "fragment": null,
                        "link": "Seaport_Centre",
                        "text": null,
                        "title": "Seaport Centre"
                    },
                    {
                        "fragment": null,
                        "link": "NeXT",
                        "text": null,
                        "title": "NeXT"
                    },
                    {
                        "fragment": null,
                        "link": "United_States_Adopted_Name",
                        "text": "USAN",
                        "title": "United States Adopted Name"
                    },
                    {
                        "fragment": null,
                        "link": "Vantictumab",
                        "text": null,
                        "title": "vantictumab"
                    },
                    {
                        "fragment": null,
                        "link": "IgG2",
                        "text": null,
                        "title": "IgG2"
                    },
                    {
                        "fragment": null,
                        "link": "Frizzled",
                        "text": null,
                        "title": "Frizzled"
                    },
                    {
                        "fragment": null,
                        "link": "Demcizumab",
                        "text": null,
                        "title": "demcizumab"
                    },
                    {
                        "fragment": null,
                        "link": "DLL4",
                        "text": null,
                        "title": "DLL4"
                    },
                    {
                        "fragment": null,
                        "link": "Cancer_stem_cell",
                        "text": null,
                        "title": "cancer stem cell"
                    },
                    {
                        "fragment": null,
                        "link": "Celgene",
                        "text": null,
                        "title": "Celgene"
                    },
                    {
                        "fragment": null,
                        "link": "Demcizumab",
                        "text": null,
                        "title": "demcizumab"
                    },
                    {
                        "fragment": null,
                        "link": "Stanford_University",
                        "text": null,
                        "title": "Stanford University"
                    },
                    {
                        "fragment": null,
                        "link": "Cancer_stem_cell",
                        "text": null,
                        "title": "cancer stem cell"
                    },
                    {
                        "fragment": null,
                        "link": "Dainippon_Sumitomo_Pharma",
                        "text": null,
                        "title": "Dainippon Sumitomo Pharma"
                    },
                    {
                        "fragment": null,
                        "link": "GlaxoSmithKline",
                        "text": null,
                        "title": "GlaxoSmithKline"
                    },
                    {
                        "fragment": null,
                        "link": "Astellas_Pharma",
                        "text": null,
                        "title": "Astellas Pharma"
                    },
                    {
                        "fragment": null,
                        "link": "Sanofi",
                        "text": null,
                        "title": "Sanofi"
                    },
                    {
                        "fragment": null,
                        "link": "Pfizer",
                        "text": null,
                        "title": "Pfizer"
                    },
                    {
                        "fragment": null,
                        "link": "Demcizumab",
                        "text": null,
                        "title": "demcizumab"
                    },
                    {
                        "fragment": null,
                        "link": "Tarextumab",
                        "text": null,
                        "title": "tarextumab"
                    },
                    {
                        "fragment": null,
                        "link": "Vantictumab",
                        "text": null,
                        "title": "vantictumab"
                    },
                    {
                        "fragment": null,
                        "link": "Ipafricept",
                        "text": null,
                        "title": "ipafricept"
                    },
                    {
                        "fragment": null,
                        "link": "Brontictuzumab",
                        "text": null,
                        "title": "brontictuzumab"
                    },
                    {
                        "fragment": null,
                        "link": "Bayer",
                        "text": null,
                        "title": "Bayer"
                    },
                    {
                        "fragment": null,
                        "link": "Celgene",
                        "text": null,
                        "title": "Celgene"
                    },
                    {
                        "fragment": null,
                        "link": "GlaxoSmithKline",
                        "text": null,
                        "title": "GlaxoSmithKline"
                    },
                    {
                        "fragment": null,
                        "link": "Bayer",
                        "text": null,
                        "title": "Bayer"
                    },
                    {
                        "fragment": null,
                        "link": "Chief_executive_officer",
                        "text": null,
                        "title": "chief executive officer"
                    },
                    {
                        "fragment": null,
                        "link": "Board_of_directors",
                        "text": null,
                        "title": "board of directors"
                    },
                    {
                        "fragment": null,
                        "link": "California_Healthcare_Institute",
                        "text": null,
                        "title": "California Healthcare Institute"
                    },
                    {
                        "fragment": null,
                        "link": "Biotechnology_Industry_Organization",
                        "text": null,
                        "title": "Biotechnology Industry Organization"
                    },
                    {
                        "fragment": null,
                        "link": "The_Wall_Street_Journal",
                        "text": null,
                        "title": "The Wall Street Journal"
                    },
                    {
                        "fragment": null,
                        "link": "California_Healthcare_Institute",
                        "text": null,
                        "title": "California Healthcare Institute"
                    },
                    {
                        "fragment": null,
                        "link": "Seeking_Alpha",
                        "text": null,
                        "title": "Seeking Alpha"
                    },
                    {
                        "fragment": null,
                        "link": "American_Medical_Association",
                        "text": "AMA",
                        "title": "American Medical Association"
                    },
                    {
                        "fragment": null,
                        "link": "Gen._Eng._Biotechnol._News",
                        "text": null,
                        "title": "Gen. Eng. Biotechnol. News"
                    },
                    {
                        "fragment": null,
                        "link": "Reuters",
                        "text": null,
                        "title": "Reuters"
                    },
                    {
                        "fragment": null,
                        "link": "San_Francisco_Business_Times",
                        "text": null,
                        "title": "San Francisco Business Times"
                    },
                    {
                        "fragment": null,
                        "link": "San_Francisco_Business_Times",
                        "text": null,
                        "title": "San Francisco Business Times"
                    },
                    {
                        "fragment": null,
                        "link": "Xconomy",
                        "text": null,
                        "title": "Xconomy"
                    },
                    {
                        "fragment": null,
                        "link": "University_of_Michigan_Health_System",
                        "text": null,
                        "title": "University of Michigan Health System"
                    },
                    {
                        "fragment": null,
                        "link": "American_Medical_Association",
                        "text": "AMA",
                        "title": "American Medical Association"
                    },
                    {
                        "fragment": null,
                        "link": "Category:2004_establishments_in_California",
                        "text": null,
                        "title": "Category:2004 establishments in California"
                    },
                    {
                        "fragment": null,
                        "link": "Category:2019_mergers_and_acquisitions",
                        "text": null,
                        "title": "Category:2019 mergers and acquisitions"
                    },
                    {
                        "fragment": null,
                        "link": "Category:American_companies_established_in_2004",
                        "text": null,
                        "title": "Category:American companies established in 2004"
                    },
                    {
                        "fragment": null,
                        "link": "Category:Companies_based_in_Redwood_City,_California",
                        "text": null,
                        "title": "Category:Companies based in Redwood City, California"
                    },
                    {
                        "fragment": null,
                        "link": "Category:Companies_formerly_listed_on_the_Nasdaq",
                        "text": null,
                        "title": "Category:Companies formerly listed on the Nasdaq"
                    },
                    {
                        "fragment": null,
                        "link": "Category:Pharmaceutical_companies_established_in_2004",
                        "text": null,
                        "title": "Category:Pharmaceutical companies established in 2004"
                    }
                ],
                "nbLinks": 61,
                "nbTables": 1,
                "nbTexts": 7,
                "tableExtractionDate": "2023-10-21T09:37:22.281796",
                "tables": [
                    {
                        "endOffset": 5021,
                        "startOffset": 4485,
                        "tableCaption": " Clinical pipeline, Oct 2014<ref name=\"de2014\" />",
                        "tableContent": "{| class=\"wikitable floatleft\"\n|+ Clinical pipeline, Oct 2014<ref name=\"de2014\" />\n|-\n! Name !! Target || ID !! Clinical Phase\n|-\n| [[demcizumab]] || DLL4 || OMP-21M18 || II\n|-\n| [[tarextumab]] || Notch 2/3 || OMP-59R5<ref name=\"omppr2013\" /> || II\n|-\n| [[vantictumab]] || Fzd7 || OMP-18R5<ref name=\"leuty2014\" /> || Ib\n|-\n| [[ipafricept]] || Fzd8-fc || OMP-54F28<ref name=\"grover2014\" /> || Ib\n|-\n| [[brontictuzumab]] || Notch1 || OMP-52M51 || I\n|-\n| unnamed || DLL4/VEGF || OMP-305B83 || I\n|- \n| unnamed || RSPO3 || OMP-131R10 || I\n|}",
                        "tableData": [
                            [
                                "Name",
                                "Target",
                                "ID",
                                "Clinical Phase"
                            ],
                            [
                                "demcizumab",
                                "DLL4",
                                "OMP-21M18",
                                "II"
                            ],
                            [
                                "tarextumab",
                                "Notch 2/3",
                                "OMP-59R5",
                                "II"
                            ],
                            [
                                "vantictumab",
                                "Fzd7",
                                "OMP-18R5",
                                "Ib"
                            ],
                            [
                                "ipafricept",
                                "Fzd8-fc",
                                "OMP-54F28",
                                "Ib"
                            ],
                            [
                                "brontictuzumab",
                                "Notch1",
                                "OMP-52M51",
                                "I"
                            ],
                            [
                                "unnamed",
                                "DLL4/VEGF",
                                "OMP-305B83",
                                "I"
                            ],
                            [
                                "unnamed",
                                "RSPO3",
                                "OMP-131R10",
                                "I"
                            ]
                        ],
                        "tableNum": 0
                    }
                ],
                "technology": "WikitextExtractor",
                "textExtractionDate": "2023-10-21T09:37:22.281796",
                "texts": [
                    {
                        "endOffset": 2266,
                        "index": 0,
                        "level": 0,
                        "startOffset": 0,
                        "title": null,
                        "value": "{{infobox company\n| name             = OncoMed Pharmaceuticals, Inc.\n| type             = Private (2004-13)<br />[[Public company|Public]] (2013-19)\n| industry         = [[Pharmaceutical]]\n| foundation       = [[University of Michigan]]\n| fate = Acquired by Mereo BioPharma\n| defunct = {{End date|2019|04|23}}\n| founders         = {{ubl|Michael Clarke|Max Wicha}}\n| key_people       = {{ubl|Paul Hastings (CEO)|John Lewicki (R&D chief)|Chuck Alaimo (Operations director)}}\n| location_city    = [[Redwood City, California]]\n| location_country = United States\n| num_employees    = {{ubl|83 (2013)|47 (2007)}}\n| assets           = {{currency|207.6 million|US}} <ref>{{Cite web |url=http://investor.shareholder.com/oncomed/secfiling.cfm?filingID=1564590-16-26741&CIK=1302573 |title=Archived copy |access-date=2017-01-05 |archive-date=2017-01-06 |archive-url=https://web.archive.org/web/20170106011610/http://investor.shareholder.com/oncomed/secfiling.cfm?filingID=1564590-16-26741&CIK=1302573 |url-status=dead }}</ref>\n| assets_year      = 2016\n| traded_as        = {{NASDAQ was|OMED}}\n| revenue          = {{currency|24.7 million|US}} (2012)\n| footnotes        = <ref name=\"leuty2007\"/><ref name=\"timmerman2013\"/><ref name=\"uofmhs2013pr\"/><ref name=\"leuty2014\"/>\n}}\nOncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in [[Redwood City, California]].<ref name=\"leuty2007\" />  The company was founded in August 2004 by two [[University of Michigan]] investigators, Michael Clarke and Max S. Wicha.<ref name=\"leuty2007\" /><ref name=\"uofmhs2013pr\" />  {{As of|2013}}, the company had 83 employees.<ref name=\"timmerman2013\" />  OncoMed's drug discovery work focuses on developing \"targeted antibodies against [[cancer stem cell]]s\".<ref name=\"timmerman2013\" />  The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company.<ref name=\"uofmhs2013pr\" />  OncoMed [[Initial public offering|went public]] in 2013 and was listed on [[NASDAQ]] under the [[stock symbol]] OMED.<ref name=\"timmerman2013\" /><ref name=\"uofmhs2013pr\" /> In April 2019 the company was acquired by [[Mereo BioPharma]] and delisted from the Nasdaq."
                    },
                    {
                        "endOffset": 4472,
                        "index": 1,
                        "level": 2,
                        "startOffset": 2266,
                        "title": "History",
                        "value": "Oncomed was founded in 2004.<ref>{{Cite web|url=https://www.bizjournals.com/sanfrancisco/blog/biotech/2012/05/oncomed-ipo-cancer.html|title=OncoMed files for $115 million IPO|last=Leuty|first=Ron|date=11 May 2012|website=San Francisco Business Times|access-date=2020-04-21}}</ref>\n\nIn 2007, Oncomed consolidated its operations located in [[Mountain View, California|Mountain View]] and [[Palo Alto, California]] onto the single headquarters campus at [[Seaport Centre]] in Redwood City.<ref name=\"leuty2007\" />  One of the buildings on the new campus was the former home of [[NeXT]].<ref name=\"leuty2007\" />\n\nIn 2012, OncoMed sponsored the [[United States Adopted Name|USAN]] nonproprietary name [[vantictumab]] for a human [[IgG2]] anti-[[Frizzled]] antibody, an anti-cancer therapeutic.<ref name=\"vantictumab_usan\" />  In the same year, the company sponsored the USAN name [[demcizumab]] for a human IgG2 anti-[[DLL4]] antibody, also an anti-cancer therapeutic.<ref name=\"demcizumab_usan\" />\n\nIn 2014, OncoMed entered into an anti-[[cancer stem cell]] therapeutic development agreement with [[Celgene]] encompassing [[demcizumab]] and five other biologics from OncoMed's pipeline.<ref name=\"de2014\" /><ref name=\"genengbionews2014collab\" />\n\n{{As of|2013}}, co-founder Max Wicha was the director of the University of Michigan Comprehensive Cancer Center and remained a consultant to OncoMed, while co-founder Michael Clarke had taken up a position at [[Stanford University]].<ref name=\"uofmhs2013pr\" />"
                    },
                    {
                        "endOffset": 4472,
                        "index": 2,
                        "level": 3,
                        "startOffset": 3783,
                        "title": "Competitors",
                        "value": "In 2013, OncoMed had at least two direct competitors, both public American companies: Stemline Therapeutics and Verastem.<ref name=\"timmerman2013\" />  By 2014, the list of firms pursuing therapies targeting [[cancer stem cell]]s had grown to include Boston Biomedical (a subsidiary of [[Dainippon Sumitomo Pharma]]), [[GlaxoSmithKline]], [[Astellas Pharma]], [[Sanofi]] (the American subsidiary) and [[Pfizer]]; however, Stemline and Verastem remain the only two competitors solely focused on cancer stem cells.<ref name=\"de2014\" />  One analyst holds that OncoMed is the best positioned of the three companies focused on the cancer stem cell area.<ref name=\"de2014\" />"
                    },
                    {
                        "endOffset": 6000,
                        "index": 3,
                        "level": 2,
                        "startOffset": 4472,
                        "title": "Pipeline",
                        "value": "{{As of|January 2017}}, Oncomed had seven clinical-stage drugs in development and four discovery-stage investigations; no OncoMed therapies have made it to market yet.<ref name=\"de2014\" />  Two candidate drugs being co-developed with [[Bayer]], ipafricept and vantictumab, showed in mid-2014 indications of \"causing mild-to-moderate bone-related side effects\" among Phase I clinical trial participants, an observation which led the company to halt enrollment and dosing in the trials, and which contributed to a sharp decline in share price.<ref name=\"de2014\" /><ref name=\"grover2014\" /><ref name=\"calia2014\" />\n\nDemcizumab, OMP-305B83, and OMP-131R10 are being developed in collaboration with [[Celgene]]. Tarextumab and brontictuzumab are being developed in collaboration with [[GlaxoSmithKline]] Vantictumab and ipafricept are being developed in collaboration with [[Bayer]].<ref>{{Cite web|url=http://www.oncomed.com/Pipeline.html|title=Home | Mereo BioPharma}}</ref>"
                    },
                    {
                        "endOffset": 6598,
                        "index": 4,
                        "level": 2,
                        "startOffset": 6000,
                        "title": "Corporate governance",
                        "value": "In 2013, OncoMed's [[chief executive officer]] (CEO) was Paul Hastings,<ref name=\"timmerman2013\" /> who took the post in 2006.<ref name=\"chidirectorbio\" />  {{As of|2007}}, the company's head of R&D was John Lewicki, and the director of operations was Chuck Alaimo.<ref name=\"leuty2007\" /> While serving as OncoMed's CEO, Hastings was also a member of the [[board of directors]] for the [[California Healthcare Institute]] and the Bay Area Biosciences Association, as well as chairing the board of the [[Biotechnology Industry Organization]].<ref name=\"chidirectorbio\" />"
                    },
                    {
                        "endOffset": 10552,
                        "index": 5,
                        "level": 2,
                        "startOffset": 6598,
                        "title": "References",
                        "value": "{{reflist|33em|refs=\n\n* <ref name=\"calia2014\">{{cite news | author=Calia, Michael | title=FDA Imposes Partial Hold on OncoMed Early-Stage Cancer-Drug Trial | date=13 Jun 2014 | work=[[The Wall Street Journal]] | url=https://online.wsj.com/articles/oncomed-halts-early-stage-trials-for-two-cancer-drugs-1402665121  }}</ref>\n* <ref name=\"chidirectorbio\">{{cite web | title=Paul J. Hastings | publisher=[[California Healthcare Institute]] | website=Leadership | url=http://www.chi.org/about/leadership/hastings.aspx | url-status=dead | archive-date=2 October 2011 | archive-url=https://web.archive.org/web/20111002104016/http://www.chi.org/about/leadership/hastings.aspx }}</ref>\n* <ref name=\"de2014\">{{cite news | author=De, Kanak Kanti | title=Is It Time To Consider OncoMed Pharmaceuticals Again? | date=14 Oct 2014 | work=[[Seeking Alpha]] | url=http://seekingalpha.com/article/2560445-is-it-time-to-consider-oncomed-pharmaceuticals-again  }}</ref>\n* <ref name=\"demcizumab_usan\">{{cite web | title=Statement on a nonproprietary name adopted by the USAN Council | url=https://download.ama-assn.org/resources/doc/usan/x-pub/demcizumab.pdf?cb=1417490455&retrieve=yes | format=PDF | access-date=1 Dec 2014 | id=N12/07 | publisher=[[American Medical Association|AMA]] }}{{registration required}}</ref>\n* <ref name=\"genengbionews2014collab\">{{cite news | title=OncoMed, Celgene in $3.3B+ Cancer Stem Cell Collaboration | author=Staff | date=January 1, 2014 | page=8 | work=[[Gen. Eng. Biotechnol. News]] | department=Industry Watch }}</ref>\n* <ref name=\"grover2014\">{{cite news | work=[[Reuters]] | author=Grover, Natalie | title=OncoMed halts enrollment in trials of two cancer drugs | date=13 Jun 2014 | url=https://www.reuters.com/article/us-oncomed-study-idUSKBN0EO1B920140613  }}</ref>\n* <ref name=\"leuty2007\">{{cite news | author=Leuty, Ron | title=The NeXT big thing: OncoMed finds a home | date=28 Oct 2007 | work=[[San Francisco Business Times]] | url=http://www.bizjournals.com/sanfrancisco/stories/2007/10/29/focus6.html?page=all }}</ref>\n* <ref name=\"leuty2014\">{{cite news | author=Leuty, Ron | title=OncoMed targets 4 million shares in IPO | date=5 Jul 2013 | work=[[San Francisco Business Times]] | url=http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/07/oncomed-ipo-cancer-stem-cells-bayer-gsk.html  }}</ref>\n* <ref name=\"omppr2013\">{{cite press release | publisher=OncoMed | title=OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 (Anti-Notch2/3) in Small Cell Lung Cancer (SCLC) and Amends Phase1b/2 Pancreatic Cancer Trial | url=http://files.shareholder.com/downloads/AMDA-20K1SK/3646503054x0x675682/d0fd1bf7-5edd-4aa2-8dca-e525ac9867a2/675682.pdf  | date=14 May 2013 }}</ref>\n* <ref name=\"timmerman2013\">{{cite news | author=Timmerman, Luke | work=[[Xconomy]] | location=United States | date=18 Jun 2013 | title=OncoMed Pharmaceuticals Soars in IPO Debut | url=http://www.xconomy.com/san-francisco/2013/07/18/oncomed-pharmaceuticals-soars-in-ipo-debut/  }}</ref>\n* <ref name=\"uofmhs2013pr\">{{cite press release | publisher=[[University of Michigan Health System]] | title=U-M start-up OncoMed has initial public offering | date=22 Jul 2013 | url=http://www.uofmhealth.org/news/archive/201307/u-m-start-oncomed-has-initial-public-offering   }}</ref>\n* <ref name=\"vantictumab_usan\">{{cite web | title=Statement on a nonproprietary name adopted by the USAN Council | url=https://download.ama-assn.org/resources/doc/usan/x-pub/vantictumab.pdf?cb=1417489538&retrieve=yes | format=PDF | date=28 Nov 2012 | id=N12/155 | publisher=[[American Medical Association|AMA]] }}{{registration required}}</ref>\n\n}}"
                    },
                    {
                        "endOffset": 11054,
                        "index": 6,
                        "level": 2,
                        "startOffset": 10552,
                        "title": "External links",
                        "value": "* {{Official website}}\n* {{Finance links\n| name = OncoMed\n| symbol = OMED\n| sec_cik = 1302573\n| yahoo = OMED\n| google = OMED\n| bloomberg = OMED:US\n}}\n\n{{Authority control}}\n\n[[Category:2004 establishments in California]]\n[[Category:2019 mergers and acquisitions]]\n[[Category:American companies established in 2004]]\n[[Category:Companies based in Redwood City, California]]\n[[Category:Companies formerly listed on the Nasdaq]]\n[[Category:Pharmaceutical companies established in 2004]]"
                    }
                ]
            }
        ],
        "statsMetadata": {
            "textSize": 10132
        },
        "preprocessingMetadata": [
            {
                "technologyResults": [
                    {
                        "dagobah": {
                            "debug": {
                                "cpaTaskTimeSec": 0.04,
                                "memoryUsage": 0.0,
                                "entityScoringTimeSec": 100.69,
                                "ceaTaskTimeSec": 3.16,
                                "abnormalLookupMentions": [],
                                "ctaTaskTimeSec": 2.9,
                                "avgLookupCandidate": 83.38,
                                "subgraphConstructionTimeSec": 18.72
                            },
                            "preprocessed": {
                                "primitiveTyping": [
                                    {
                                        "typing": [
                                            {
                                                "typingLabel": "UNKNOWN",
                                                "typingScore": 1.0
                                            }
                                        ],
                                        "columnIndex": 0
                                    },
                                    {
                                        "typing": [
                                            {
                                                "typingLabel": "UNKNOWN",
                                                "typingScore": 0.71
                                            },
                                            {
                                                "typingLabel": "CARDINAL",
                                                "typingScore": 0.14
                                            },
                                            {
                                                "typingLabel": "ORG",
                                                "typingScore": 0.14
                                            }
                                        ],
                                        "columnIndex": 1
                                    },
                                    {
                                        "typing": [
                                            {
                                                "typingLabel": "UNKNOWN",
                                                "typingScore": 1.0
                                            }
                                        ],
                                        "columnIndex": 2
                                    },
                                    {
                                        "typing": [
                                            {
                                                "typingLabel": "UNKNOWN",
                                                "typingScore": 0.71
                                            },
                                            {
                                                "typingLabel": "CARDINAL",
                                                "typingScore": 0.29
                                            }
                                        ],
                                        "columnIndex": 3
                                    }
                                ],
                                "headerInfo": {
                                    "hasHeader": true,
                                    "headerScore": 0.03,
                                    "headerLabel": [
                                        "Name",
                                        "Target",
                                        "ID",
                                        "Clinical Phase"
                                    ],
                                    "headerPosition": 0
                                },
                                "primaryKeyInfo": {
                                    "primaryKeyScore": 0.03,
                                    "primaryKeyPosition": 0,
                                    "hasPrimaryKey": true
                                },
                                "tableOrientation": {
                                    "orientationScore": 0.1,
                                    "orientationLabel": "HORIZONTAL"
                                }
                            },
                            "executionTimeSec": {
                                "preprocessingTime": 0.25,
                                "totalTime": 135.37,
                                "lookupTime": 4.390000000000001
                            },
                            "annotated": {
                                "CTA": [
                                    {
                                        "annotation": [
                                            {
                                                "coverage": 0.57,
                                                "score": 0.04,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q11173"
                                            },
                                            {
                                                "coverage": 0.57,
                                                "score": 0.04,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q113145171"
                                            },
                                            {
                                                "coverage": 0.57,
                                                "score": 0.03,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q578779"
                                            },
                                            {
                                                "coverage": 0.57,
                                                "score": 0.03,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q20026787"
                                            },
                                            {
                                                "coverage": 0.57,
                                                "score": 0.03,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q21146257"
                                            }
                                        ],
                                        "column": 0
                                    },
                                    {
                                        "annotation": [
                                            {
                                                "coverage": 1.0,
                                                "score": 0.08,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q7187"
                                            },
                                            {
                                                "coverage": 1.0,
                                                "score": 0.06,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q3511065"
                                            },
                                            {
                                                "coverage": 1.0,
                                                "score": 0.06,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q863908"
                                            },
                                            {
                                                "coverage": 1.0,
                                                "score": 0.06,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q50365914"
                                            }
                                        ],
                                        "column": 1
                                    },
                                    {
                                        "annotation": [
                                            {
                                                "coverage": 0.57,
                                                "score": 0.03,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q318"
                                            },
                                            {
                                                "coverage": 0.57,
                                                "score": 0.02,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q249389"
                                            }
                                        ],
                                        "column": 2
                                    },
                                    {
                                        "annotation": [
                                            {
                                                "coverage": 0.29,
                                                "score": 0.02,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q10417670"
                                            },
                                            {
                                                "coverage": 0.29,
                                                "score": 0.02,
                                                "label": "Dump not contain this info",
                                                "uri": "http://www.wikidata.org/entity/Q2462003"
                                            }
                                        ],
                                        "column": 3
                                    }
                                ],
                                "tableDataRevised": [
                                    [
                                        "Name",
                                        "Target",
                                        "ID",
                                        "Clinical Phase"
                                    ],
                                    [
                                        "demcizumab",
                                        "DLL4",
                                        "OMP-21M18",
                                        "II"
                                    ],
                                    [
                                        "tarextumab",
                                        "Notch 2/3",
                                        "OMP-59R5",
                                        "II"
                                    ],
                                    [
                                        "vantictumab",
                                        "Fzd7",
                                        "OMP-18R5",
                                        "Ib"
                                    ],
                                    [
                                        "ipafricept",
                                        "Fzd8-fc",
                                        "OMP-54F28",
                                        "Ib"
                                    ],
                                    [
                                        "brontictuzumab",
                                        "Notch1",
                                        "OMP-52M51",
                                        "I"
                                    ],
                                    [
                                        "unnamed",
                                        "DLL4/VEGF",
                                        "OMP-305B83",
                                        "I"
                                    ],
                                    [
                                        "unnamed",
                                        "RSPO3",
                                        "OMP-131R10",
                                        "I"
                                    ]
                                ],
                                "CPA": [],
                                "CEA": [
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q5255127"
                                        },
                                        "column": 0,
                                        "row": 1
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q25098812"
                                        },
                                        "column": 0,
                                        "row": 2
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q7915216"
                                        },
                                        "column": 0,
                                        "row": 3
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q25326688"
                                        },
                                        "column": 0,
                                        "row": 5
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q101552401"
                                        },
                                        "column": 0,
                                        "row": 6
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q101552401"
                                        },
                                        "column": 0,
                                        "row": 7
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q29737895"
                                        },
                                        "column": 1,
                                        "row": 1
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q29748186"
                                        },
                                        "column": 1,
                                        "row": 2
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q18250693"
                                        },
                                        "column": 1,
                                        "row": 3
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q24409995"
                                        },
                                        "column": 1,
                                        "row": 4
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q21130409"
                                        },
                                        "column": 1,
                                        "row": 5
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.07,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q29758779"
                                        },
                                        "column": 1,
                                        "row": 6
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q29766951"
                                        },
                                        "column": 1,
                                        "row": 7
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.06,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q89726233"
                                        },
                                        "column": 2,
                                        "row": 1
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.05,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q76720343"
                                        },
                                        "column": 2,
                                        "row": 2
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.06,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q89726258"
                                        },
                                        "column": 2,
                                        "row": 3
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.05,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q12406198"
                                        },
                                        "column": 2,
                                        "row": 4
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.06,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q83924520"
                                        },
                                        "column": 2,
                                        "row": 5
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.05,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q84997833"
                                        },
                                        "column": 2,
                                        "row": 6
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.06,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q48975959"
                                        },
                                        "column": 2,
                                        "row": 7
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q5994877"
                                        },
                                        "column": 3,
                                        "row": 1
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q5994877"
                                        },
                                        "column": 3,
                                        "row": 2
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q16743891"
                                        },
                                        "column": 3,
                                        "row": 3
                                    },
                                    {
                                        "annotation": {
                                            "score": 0.08,
                                            "label": "Dump not contain this info",
                                            "uri": "http://www.wikidata.org/entity/Q16743891"
                                        },
                                        "column": 3,
                                        "row": 4
                                    }
                                ]
                            }
                        },
                        "index": 0
                    }
                ],
                "technologyExecution": {
                    "beginDate": "2024-04-03T08:23:48.957893",
                    "endDate": "2024-04-03T08:26:05.574214"
                },
                "technology": {
                    "name": "DAGOBAH Table Annotation",
                    "company": "Orange",
                    "id": "dagobah_anotation",
                    "type": "table",
                    "version": "Unknown"
                }
            }
        ]
    }
}
